TOLREMO therapeutics AG
1 clinical trials · Sponsor
◉ Watch TOLREMO therapeutics AG
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (NCT06403436) | TOLREMO therapeutics AG | 2023-11-07 |
Track TOLREMO therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.